Newly FDA-Approved Drugs Give Hope to People with Pulmonary Fibrosis

Those who suffer from idiopathic pulmonary fibrosis (IPF) may be breathing a little easier. In October 2014, the Food and Drug Administration approved two new drugs for IPF — the first ever produced that can treat this disease. IPF is a scarring or thickening of the lungs that has no known cause. As the scarring … Read More